Clinical Chemistry


Harmless Bacteria Thrive in Patients with Inflammatory Bowel Disease
The survival and proliferation of usually harmless Escherichia coli in the gut of inflammatory bowel disease patients may now be better understood, as fundamental mechanism through which the bacteria can thrive during flare-ups has been defined. More...26 May 2015



In Other News
Rapid Sepsis Assay Now Available for Clinical Chemistry Analyzers
Rapid Early Pregnancy Blood Test Approved by FDA
Markers Predicting Obesity Can Be Detected In Urine
Test Kit Launched for Crohn’s and Ulcerative Colitis
Breath-Test Helps Diagnosis of Delayed Gastric Emptying
New Blood Test Can Predict Future Breast Cancer
Gastric Cancer Detected Through Exhaled Breath
Next Generation of Rapid Diagnostic Assays Will Combine Disposable Test Materials with Smartphone Applications
Patient-Specific Diabetes Report Helps Understand Test Results and Implement Recommendations
Malaria Biomarkers Detected In Human Breath
Gold Nanoparticle-Based Test Better for Prostate Cancer Diagnosis Than PSA
Ready-to-Use Control Determines Linearity for Special Diabetes Tests
Sterile Urine Notion Shown to Be a Myth
Excessive Phlebotomy in Cardiac Surgical Care Leads to Anemia
Advanced Miniature In-Line Blood Gas Analyzer Launched in Europe
Monitoring Calcitriol May Help Prevent Chronic Heart Failure Death
Advanced Screening Test Improves Colorectal Cancer Survival Rates
Urinary Proteins Kidney Cancer Biomarkers
Routine Blood Glucose Value Correlates with Diabetes Risk
Biomarkers Show Promise Improving Prostate Cancer Care
Urine Test Predicts Heart Failure Patients' Risk of Kidney Injury
Blood Test Aids Early Detection of Rheumatoid Arthritis
Autoantibodies Are Early Diabetes Warning Signs
The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.








